Monobenzone 40% is a higher-concentration depigmenting cream primarily used for extensive vitiligo cases, aiming to uniformly lighten remaining pigmented skin to match white patches. Compared to the standard 20% formulation, it may accelerate melanin loss from melanocytes through enhanced excretion and potential cell destruction, though responses can vary and depigmentation remains largely permanent. This strength appears in compounded or specific products like Benoquin variants, often requiring dermatologist oversight for application on targeted areas. Studies note erratic outcomes across concentrations, with faster effects possible but similar irreversible skin lightening.
​